Lovelace Biomedical Research Institute
Albuquerque, NM
- UEI
- MBT9RXJJ7428
- CAGE
- 3MMH4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 541380 Testing Laboratories and Services
- 541511 Custom Computer Programming Services
- 541512 Computer Systems Design Services
- 541513 Computer Facilities Management Services
- 541519 Other Computer Related Services
- 541611 Administrative Management and General Management Consulting Services
- 541690 Other Scientific and Technical Consulting Services
- Corporate family
-
-
Lovelace Biomedical Research Institute
MBT9RXJJ7428
- Lovelace Biomedical And Environmental Research Institute, Inc. N1UBCLRAPNG6
- Mind Research Network QUF6D3M4P2G1
-
Lovelace Biomedical Research Institute
MBT9RXJJ7428
- SAM.gov registration date
- Physical address
- 2425 Ridgecrest Dr SE, Albuquerque, NM 87108, USA
- Website
- lovelacebiomedical.org
- Founded
- 1947
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Consumer Discretionary
- Media
- Advertising
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| GLP repeat dose toxicology study for a live-attenuated respiratory virus vaccine. | Office of Logisitics and Acquisition Operations | $339,534 | |
| Nicotine flux: investigating the impact of ends output power and heating element on abuse liability | Food and Drug Administration | $3,017,553 | |
| Rtor BIO-AMT-2312: assessment of the therapeutic potential of chloroquine and oseltamivir in two (2) lethal models of… | Office of the Assistant Secretary for Preparedness and Response | $3,723,027 | |
| Applying neuromodulation to boost the efficacy of motivational interviewing - the use of cannabis and alcohol is… | National Institute on Drug Abuse | $2,690,732 | |
| The synchrony study: a randomized controlled trial of music training for children - abstract recent estimates indicate… | National Institute on Alcohol Abuse and Alcoholism | $1,705,771 |
About Lovelace Biomedical Research Institute
Lovelace Biomedical Research Institute is a not-for-profit preclinical contract research organization located in Albuquerque, New Mexico, that provides comprehensive scientific research and development services to federal agencies. The organization specializes in delivering advanced preclinical research capabilities across various therapeutic areas, including animal studies, analytical testing, disease model development, inhalation toxicology, medical countermeasure testing, and product development. Registered in SAM.gov since 2003, Lovelace Biomedical Research Institute serves as a parent organization with extensive experience supporting federal research needs through contract and grant awards.
Through federal contract awards, Lovelace Biomedical Research Institute has performed diverse scientific services for multiple federal agencies. Notable contract work includes toxicological studies for the Food and Drug Administration's Center for Tobacco Products, pulmonary function testing for the National Heart, Lung, and Blood Institute, and respiratory interaction studies for the National Institute on Drug Abuse. The organization has executed contracts examining cigarette sensory effects, synthetic cooling agents, and potential treatments for respiratory depression. Most contracts were awarded without specific small business set-aside designations and involved multiple federal agencies such as NIH, FDA, and ASPR, with contract values ranging from a few thousand to several million dollars. Lovelace has worked as both a prime and sub-contractor, collaborating with entities like Research Triangle Institute and SRI International.
The organization's federal grant awards demonstrate a strong focus on advanced neuroscience, medical research, and innovative therapeutic investigations. Grants from agencies like the National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, and the National Science Foundation have supported projects ranging from music training interventions for children with Fetal Alcohol Spectrum Disorder to neuroimaging studies of traumatic brain injury. Other significant grant work includes research on cognitive sequelae in post-acute COVID-19 syndrome, mechanisms of cerebral microcirculation, and studies on incarcerated populations' mental health outcomes. These grants often involve collaborations with academic institutions like the University of New Mexico and involve sophisticated research methodologies including neuroimaging, behavioral assessments, and advanced statistical analyses.
Lovelace Biomedical Research Institute holds multiple significant federal contract Indefinite Delivery/Indefinite Quantity (IDIQ) contracts across various domains. These include a $136.6 million contract with the National Institute of Allergy and Infectious Diseases for evaluation and testing services for vaccines, a $48.8 million contract with the National Center for Advancing Translational Sciences for pharmacology studies and animal model development, and a $100 million contract with the Office of the Assistant Secretary for Preparedness and Response for biological animal model and medical countermeasure development. These IDVs cover a wide range of services including preclinical product development, safety evaluations, toxicology studies, and support for infectious disease research. Task orders have been issued by agencies like FDA, ASPR, and NIH, demonstrating the breadth and depth of Lovelace's capabilities in supporting complex federal research and development needs.
Contract vehicles
Quick answers
What is Lovelace Biomedical Research Institute's UEI?
Lovelace Biomedical Research Institute's Unique Entity ID (UEI) in SAM.gov is MBT9RXJJ7428.
What is Lovelace Biomedical Research Institute's CAGE code?
Lovelace Biomedical Research Institute's CAGE code is 3MMH4.
What is Lovelace Biomedical Research Institute's primary NAICS code?
Lovelace Biomedical Research Institute's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Lovelace Biomedical Research Institute located?
Lovelace Biomedical Research Institute's physical address in SAM.gov is 2425 Ridgecrest Dr SE, Albuquerque, NM 87108, USA.
Is Lovelace Biomedical Research Institute registered in SAM.gov?
Yes. Lovelace Biomedical Research Institute's SAM.gov registration is active through January 12, 2027.
Which contract vehicles does Lovelace Biomedical Research Institute hold?
Lovelace Biomedical Research Institute holds a place on 5 federal contract vehicles, including MAS, OMNIBUS IV and Resources to Advance Pediatrics and HIV Prevention Science.
What is Lovelace Biomedical Research Institute's most recent federal award?
Lovelace Biomedical Research Institute's most recent federal contract award is GLP repeat dose toxicology study for a live-attenuated respiratory virus vaccine (75N98026F00001), from Office of Logisitics and Acquisition Operations, on September 28, 2026.
On GovTribe
See Lovelace Biomedical Research Institute's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors